Treatment of interleukin-2-induced thrombocytopenia by intravenous immunoglobulin.
Cottin
V
V
Négrier
S
S
Ranchère
J Y
JY
Mercatello
A
A
Merrouche
Y
Y
Négrier
C
C
Philip
T
T
D018262:Adenocarcinoma, Clear Cell / Q000628:therapy; D000368:Aged; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000628:therapy; D008297:Male; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy*
D016756:Immunoglobulins, Intravenous; D007376:Interleukin-2